Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects
Clinical trial NCT02807233 · COMPLETED
Trial details
- NCT number
- NCT02807233
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-09-01
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.